REQUEST A DEMO
Total
USD $0.00
Search more companies

Illumia Therapeutics Pte. Ltd. (Singapore)

Main Activities: Other Personal Care Services
Full name: Illumia Therapeutics Pte. Ltd. Profile Updated: August 14, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Illumia Therapeutics Pte. Ltd. is an enterprise in Singapore, with the main office in Singapore. The company operates in the Other Personal Care Services industry. Illumia Therapeutics Pte. Ltd. was incorporated on July 09, 2019. There are currently Above 50 (estimated) people employed by Illumia Therapeutics Pte. Ltd.. In 2025, the company reported a net sales revenue increase of 11.72%. Its’ total assets recorded a growth of 21.05%.

Legal Address
435 Orchard Road, #11-00, Wisma Atria, Singapore 238877
Singapore; Singapore; Postal Code: 238877

Contact Details: Purchase the Illumia Therapeutics Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Illumia Therapeutics Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Illumia Therapeutics Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Illumia Therapeutics Pte. Ltd. report to view the information.
Incorporation Date:
July 09, 2019
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Illumia Therapeutics Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
11.72%
Total Operating Revenue
11.72%
Net Profit/Loss for the Period
N/A
Total Assets
21.05%
Total Equity
70.68%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
-1.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?